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Abstract
Background and purpose Multi-phase postmortem CT an-
giography (MPMCTA) is increasingly being recognized as a
valuable adjunct medicolegal tool to explore the vascular
system. Adequate interpretation, however, requires knowl-
edge about the most common technique-related artefacts.
The purpose of this study was to identify and index the
possible artefacts related to MPMCTA.
Material and methods An experienced radiologist blinded
to all clinical and forensic data retrospectively reviewed 49
MPMCTAs. Each angiographic phase, i.e. arterial, venous
and dynamic, was analysed separately to identify phase-
specific artefacts based on location and aspect.
Results Incomplete contrast filling of the cerebral venous
system was the most commonly encountered artefact,
followed by contrast agent layering in the lumen of the
thoracic aorta. Enhancement or so-called oedematization of
the digestive system mucosa was also frequently observed.
Conclusion All MPMCTA artefacts observed and described
here are reproducible and easily identifiable. Knowledge
about these artefacts is important to avoid misinterpreting
them as pathological findings.
Keywords Postmortem CT . Postmortem angiography .
Artefacts . Forensic radiology . Minimally invasive autopsy
Introduction
The evaluation of the human vascular system has always
been a great challenge in postmortem investigations. First
experiences using vascular casts enabling visualization of
the vascular anatomy were performed in the seventeenth and
eighteenth centuries by pioneers such as De Graaf, Ruysch,
and Lower [1]. After the discovery of X-rays, postmortem
angiography underwent a boom in the beginning of the
twentieth century, during which hundreds of methods were
developed to visualize the vascular system [2]. Especially the
coronary arteries were investigated mostly using a technique
described by Schlesinger [3] in 1938. Nevertheless, postmor-
tem angiography had almost disappeared at the end of the
twentieth century.
Nowadays, the status of postmortem angiography seems
to be again in a state of change thanks to the increasing
implementation of modern cross-sectional imaging tech-
niques into postmortem investigations. The use of multi-
detector computed tomography in forensic medicine in par-
ticular is becoming more and more widespread [4–10]. Its
introduction into forensic departments has added a rapid and
easy method for collecting findings and conducting a digital
documentation of the body. This new trend has naturally led
to an increased interest in CT angiography. In fact, different
research groups have already proposed new techniques [11]
for performing CT angiography of the whole body [12–15]
or of the coronary arteries only [16, 17].
C. Bruguier and P. J. Mosimann contributed equally to this work.
C. Bruguier (*) : P. Mangin : S. Grabherr
University Centre of Legal Medicine, Lausanne–Geneva,
University Hospital of Lausanne, Rue du Bugnon 21,
1011 Lausanne, Switzerland
e-mail: christine.bruguier@chuv.ch
C. Bruguier : P. J. Mosimann :A. Uské : F. Doenz
Department of Diagnostic and Interventional Radiology,
University Hospital of Lausanne, Rue du Bugnon 46,
1011 Lausanne, Switzerland
P. Vaucher
University Centre of Legal Medicine, Lausanne–Geneva,
University of Geneva, Rue Michel-Servet 1,
1211 Geneva 4, Switzerland
C. Jackowski
Center for Forensic Imaging, Institute of Forensic Medicine,
University of Bern, Buehlstr. 20,
3012 Bern, Switzerland
Int J Legal Med (2013) 127:639–652
DOI 10.1007/s00414-013-0840-9
Recently, a new, standardized protocol for postmor-
tem CT angiography has been developed that is easy to
handle and reproducible and that permits a minimally
invasive approach to studying blood vessels. This tech-
nique, called multiphase postmortem CT angiography
(MPMCTA), consists of the acquisition of one native
scan and three different phases of angiography: an arte-
rial phase, a venous phase and a dynamic phase [18].
While the first two phases are performed to fill the
arterial and the venous system to distinguish lesions in
one system from the other, the dynamic phase is
performed to confirm diagnosis.
Thanks to a complete filling of the vascular system
of the head, thorax and abdomen, the images obtained
by MPMCTA are of high quality. The performance of
this exam allows the detection of haemorrhages, vessels
rupture, stenosis, aneurysms and dissection even for
small vessels [19–21]. This capability is unlike standard
autopsy in which the search for these lesions is difficult
and time-consuming or even impossible when small
vessels are concerned. For this reason, the MPMCTA
technique is used in our Institute of Legal Medicine
routinely to contribute to the forensic expertise. For
correct interpretation, two advanced radiologists (one
vascular radiologist and one neuroradiologist) jointly
evaluate all obtained images together with one forensic
pathologist experienced in forensic imaging. However,
in examining images from postmortem CT angiography,
the different specialists have observed artefacts that
seem to appear regularly in specific anatomical areas
and that can induce misinterpretation. These artefacts
differ from those typically observed on CTAs in the
physiological conditions of a living body, where the
heart and aortic pulsations as well diaphragmatic move-
ments may induce motion artefacts and mimic aortic
dissections or pulmonary embolism [22, 23]. These ob-
servations lead us to ask ourselves the following ques-
tions: Does the perfusion of a dead body produce
artefacts? Does the vascular system of a postmortem
body react in the same way as the living body to
contrast agent? And finally, do postmortem changes in
the tissues generate artefacts?
Although many publications deal with the advantages
and results of postmortem CT angiography, to our knowl-
edge, none systematically describes the artefacts that can be
observed. To interpret the obtained images, radiologists and
forensic pathologists need to know what artefacts to antici-
pate. Because the MPMCTA technique was developed with
the intention of applying it in routine investigations, knowl-
edge about such pitfalls is highly important. The purpose of
this study, therefore, was to identify and categorize
MPMCTA artefacts according to their type, anatomical lo-
cation and timing of appearance during the angiography.
Material and methods
Inclusion and exclusion criteria
We retrospectively included 54 consecutive MPMCTAs
performed between January 2008 and September 2008
according to the standardized protocol proposed by
Grabherr et al. in 2011 [18]. All MPMCTAs were performed
before the conventional autopsy. Incomplete MPMCTAs or
cases in which the order of the different phases was changed
were excluded from the study. Subjects were included inde-
pendent of the cause of death or medical history.
Subjects
Out of our 54 cases, five were excluded because of incom-
plete protocol implementations, such as a missing abdomi-
nal dynamic phase or inversion of the arterial and venous
phases. In the remaining 49 subjects, there were 34 males
and 15 females, median age and BMI were 52 years [16–
87 years] and 24.9 [17–36], respectively. MPMCTA was
performed within 24 h after death in 36 cases, within 24–
48 h in seven cases, within 48–72 h in four cases and after
more than 72 h in two cases. There were 27 natural deaths
(such as sudden cardiac arrest), 13 traumatic deaths (such as
from motor vehicle accidents) and nine deaths due to intox-
ication (recreational or prescribed drugs). All data about the
examined cases are provided in Table 1.
Postmortem examinations
A native CT scan was performed prior to any manipulation
of the corpse using an eight-row CT unit (CT LightSpeed 8,
GE Healthcare, Milwaukee, WI, USA) with scan parameters
as given in Table 2 covering the brain, the neck, the chest
and the abdomen to the ischium. CT-guided sampling was
then performed by trained forensic radiographers [18, 24]
and included bilateral needle lung biopsies and puncture of
the right cardiac cavities, gallbladder and bladder to sample
cardiac blood, bile and urine, respectively.
To subsequently perform MPMCTA, unilateral cannula-
tion of the femoral vessels was achieved using 16- or 18-Fr
cannulae (MAQUET Gmbh & Co. KG, Rastatt, Germany)
for the artery or vein, respectively. A recently developed
pressure-controlled perfusion device (Virtangio®, Fumedica
AG, Muri, Switzerland) was used to inject a mixture
of contrast agent (Angiofil®, Fumedica AG, Muri,
Switzerland) with paraffin oil (paraffinum liquidum,
obtained in local pharmacy). According to the protocol
proposed by Grabherr et al. [18], the arterial phase of angi-
ography was then carried out after having injected 1,200 ml
contrast-agent mixture (6 % Angiofil®) retrograde during
90 s into the arterial system. For the venous phase of
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angiography, 1,800 ml of contrast-agent mixture was
injected antegrade into the femoral vein during 135 s. At
least, the dynamic phase of MPMCTA was carried out by
injecting further 500 ml of contrast-agent mixture into the
femoral artery and performing the radiological data acquisi-
tion during an ongoing perfusion with 3 ml/s during 150 s.
The used scan parameters for angiography are given in
Table 2. The data acquisition during the angiography cov-
ered the same anatomical regions as the native CT scan
(head, neck, thorax and abdomen).
For each exam, a board-certified forensic pathologist
with experience in forensic imaging and two board-
certified radiologists specialized in vascular- and neuro-
radiology established a detailed radiological report de-
scribing all findings in the different phases. These
reports are edited as a routine in our centre in order
to complete the autopsy reports. Two forensic patholo-
gists, one board-certified and one in training, subse-
quently carr ied out a conventional autopsy in
accordance with international guidelines [25, 26], which
was documented in a detailed autopsy report edited by
the two physicians.
Data collection
Based on more than 150 MPMCTAs interpreted at our
institution over the last 2 years, we established a list of
all encountered artefacts that have been described in the
routine radiological reports. According to our experi-
ence, they typically occur in the digestive and vascular
systems, as well as at biopsy and puncture sites. With
this knowledge, we distinguished two types of artefacts
according to the anatomical area in which they accrued.
The first area was the vascular system of the neck and
the brain, and the second area included the chest and
the abdomen.
The data of the first area could be extracted from the
routine radiological reports edited by two radiologists and
one forensic pathologist. The data of the second area were
not available in the radiological report and were therefore
assembled by a board-certified radiologist who was blinded
to the results of the previous radiological reports, the results
of the autopsies and all case information.
First anatomical area: vascular system of the neck and the
brain Our experiences showed that artefacts in this anatom-
ical area are visible as incomplete perfusion of the vessels,
especially the venous system of the head. In order to eval-
uate the perfusion of the vessels of the neck and the brain,
we investigated the appearance of these artefacts. As incom-
plete fillings of the vessels are documented in the routine
radiological report, we extracted these data retrospectively.
To quantify the degree of contrast perfusion of the cerebral
venous system, we developed a nine-point (from 0 to 8)
scaling system, as shown in Fig. 1.
Second anatomical area: chest and the abdomen In order to
investigate the prevalence of artefacts in the chest and
abdomen, we based our study on the experiences we had.
A total of 28 sites in which artefacts have been described
during the routine radiological interpretation of the last
years have been selected. In order to allow an evaluation
Fig. 1 Degree of retrograde contrast filling of the head and neck venous
system: 0: no opacification of the precerebral and cerebral veins, 1 partial
opacification of the jugular veins, 2 full opacification of the jugular veins,
3 opacification of the sigmoid sinus, 4 opacification of the transverse
sinus, 5 opacification of the torcular, 6 opacification of 1/3 of the superior
sagittal sinus, 7 opacification of 2/3 of the superior sagittal sinus and 8 full
opacification of superior sagittal sinus (corresponding to a complete
opacification of the cerebral venous system)
Table 2 Scan parameters used for acquisition of the radiological images (for native CT scans and the different angiographic phases)
Field of view
(cm)
Slice
thickness
Reconstruction interval
(mm)
Tube voltage
(kV)
Milliamperes
(Ma modulated)
Tube rotation (s) Pitch
Native 50 1.25 1 120 280 0.8 0.875
Arterial 50 1.25 0.6 120 280 0.8 0.875
Venous 50 2.5 2 120 280 0.8 0.875
Dynamic 50 2.5 2 120 280 0.8 0.875
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in a systematic fashion, these 28 sites have been entered into
an Excel spreadsheet. Each artefact was specifically defined
by the board-certified forensic pathologist and radiologist
used to investigate the radiological data and explained to the
blinded radiologist in charge of reviewing the exams (see
Table 3). This radiologist evaluated each site in all three
angiographic phases. Artefacts were coded as 0, 1 or 2,
respectively, if they were present, absent or impossible to
evaluate (e.g. the region of interest was outside the scanned
field of view). Space was given for free comments, such as
the identification of a new artefact. The defined artefacts
were observed in the digestive system, the vascular system
and at sampling sites.
Digestive system
Artefacts of the gastrointestinal mucosa were graded as fol-
lows: (1) mucosal enhancement only (normal thickness), (2)
oedematous enhancement (thickenedmucosa) and (3) contrast
agent extravasation into the digestive lumen (Fig. 2a).
Peripancreatic contrast extravasation was also evaluated as a
separate artefact (Fig. 2b).
Vascular system
The quality of the perfusion was determined by the degree
of contrast filling on each angiographic phase, i.e. full,
partial or no vessel opacification (Fig. 3a). Layering of the
contrast agent, as characterized by a denser layer of contrast
above the more dependent stagnating and hypodense blood
(Fig. 3b), was the most prominent vascular artefact in our
early experience. We thus predefined a number of target
vessels where this seemed to occur the most. In the arterial
phase, we examined the left cardiac cavities, the ascending
and descending aorta, the aortic arch, the coronary arteries
and the pulmonary veins. Sites of interest in the venous
phase were the right cardiac cavities, the pulmonary arteries,
the superior and inferior vena cava, the portal vein and the
renal veins. In the dynamic phase, all of the aforementioned
arterial and venous sites were re-evaluated.
Table 3 List and definition of artefacts
Artefact Definition Localization Phase of angiography
Arterial Venous Dynamic
Filling defects Inhomogeneous opacification without
layering
Ascending aorta–aortic arch–
descending aorta–coronary arteries–
pulmonary veins
X X
Left atrium–left ventricle–right
atrium–right ventricle
X X X
Pulmonary arteries–superior vena
cava–inferior vena cava portal veins
X X
Layering Hyperdense layer of contrast above
stagnating and hypodense blood
Ascending aorta–aortic arch–
descending aorta–coronary arteries–
pulmonary veins
X X X
Left atrium–left ventricle–right
atrium–right ventricle
X X X
Pulmonary arteries–superior vena
cava–inferior vena cava portal veins
X X
Peripancreatic contrast
extravasation
Visualization of contrast agent around
the pancreas
Pancreas X X X
Extravasation of contrast
from renal vein
Visualization of contrast around the
renal vein
Right renal vein–left renal vein X X
Mucosal enhancement
(digestive system)
Enhancement of the mucosa without
increase of thickness
Stomach–duodenum–colon X X X
Oedematous enhancement
of mucosa (digestive
system)
Enhancement of the mucosa with
increasing thickness (≥0.5 cm)
Stomach–duodenum–colon X X X
Intraluminal extravasation
(digestive system)
Extravasation of contrast agent into the
lumen of the digestive system
Stomach–duodenum–colon X X X
Artefacts related to
sampling
Extravasation of contrast resulting from
the passage of the biopsy or puncture
needle
Heart–lungs–gallbladder–bladder X X X
Other artefacts All other non-defined artefacts
observed
– X X X
X evaluated in this phase of angiography
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Artefacts related to sampling
Because samples are collected prior to the injection of
contrast agent into the vascular system, the passage of the
needle understandably can create artefacts resulting from
lesions of small vessels (Fig. 4). The second radiological
view performed by the observer should therefore indicate
whether an artefact was visible at each puncture site or not.
Evaluation of the relationship between case information and
the presence of artefacts To verify whether certain parameters
influenced the presence or the amount of artefacts, the follow-
ing data were extracted from the autopsy reports: age, sex and
BMI of the individual; presumed postmortem interval between
the death and the MPMCTA; and circumstance of death
(Table 1). To simplify our statistical analyses, circumstances
of death were divided into polytrauma, sudden death from
natural or unknown causes and intoxication, designated as
groups 1, 2 and 3, respectively.
Verification of the presence of artefacts In order to verify
that the described artefacts were really artefacts and no
pathological findings, all data have been correlated to the
autopsy results by viewing the autopsy reports and cross
checking the findings described there with the artefacts
described by the different radiologists.
Statistical analyses
Arithmetic means were calculated for quantitative values.
We used non-parametric tests (Wilcoxon rank-sum test for
quantitative variables, Fisher’s exact test for qualitative vari-
ables or Spearman’s rho correlation coefficient) to test cor-
relations and associations between case information and
presence of artefacts. Significance level was set at p<0.05
without adjustment for multiple testing.
Results
Neck and brain perfusion
In the arterial phase, no incomplete perfusion of the precerebral
and intracerebral arteries was observed. In the venous phase,
however, the venous system was completely opacified in only
20.4 % of cases. In the dynamic phase, this number slightly
increased to 22.4 % (Fig. 5); this means we observed an
improvement of the filling of the venous system in four cases
in the dynamic phase compared to the venous phase. The only
cases in which complete venous perfusion could be observed
were those who died due to a polytrauma (Table 4).
Evaluation of gastrointestinal artefacts
In the digestive system, artefacts could be observed regularly
(Fig. 6). Their prevalence increased slightly with an increasing
number of effected phases. The upper gastrointestinal tract
was more often affected than the lower. Artefact prevalence
was higher in the stomach, followed by the duodenum, and
artefacts were rarely observed in the large bowel. Grade 1
artefacts (enhancement of the mucosa) were more often ob-
served than grade 2 artefacts (oedematous enhancement of the
mucosa). Therefore, after the arterial phase, an artefact grade 1
could be observed in 81.6 % of the cases in the stomach, in
65.3 % in the duodenum and 59.2 % in the colon. During the
following phases, its incidence did only increase slightly
(Fig. 6a). After the arterial phase, grade 2 artefacts were
observed in 51 % of the cases in the stomach, in 22.4 % in
the duodenum and in 4.1 % in the colon. Their incidence
increased slightly during the venous phase, especially in the
colon (6.1 %) (Fig. 6b). Grade 3 artefacts (oedematous en-
hancement of the mucosa with contrast extravasation into the
Fig. 3 Artefacts in the vascular system. a Perfusion defect of the
pulmonary arteries (white arrow in the white circle). b Layer mimick-
ing a dissection of the abdominal aorta (white circle)
Fig. 2 Artefacts in the digestive system a: Axial images showing the
stomach and the 3 predefined artefacts: 1: Enhancement of the gastric
mucosa. 2: Enhancement and oedema of the gastric mucosa. 3: En-
hancement and oedema of the gastric mucosa with extravasation of
contrast agent into the gastric lumen. b: Axial image showing the
pancreatic head (red dotted) encircled with an artefactual extravasation
of contrast agent (orange arrow)
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digestive lumen) appeared more often in later phases of angi-
ography, mostly in the venous phase (in 28.6 % of the cases in
the stomach and in 6.1 % in the colon) or in the dynamic
phase (in 10.2 % of the cases in the duodenum). Modest
peripancreatic contrast extravasation was observed mostly
during the arterial phase (in 46.9 % of the cases) and more
rarely during the venous phase (Fig. 6c).
Artefacts of the vascular system
Contrast agent layering
Contrast agent layering was observed in all of the predefined
vessels (Fig. 7), proportionally more so in larger arteries and
veins (in 67.3 % of the cases in the descending aorta during
the arterial phase and the inferior vena cava during the
venous phase). It was also frequent in the cardiac cavities
(in 40.8 % of the cases in the left atrium; in 55.1 % in the
right atrium; in 16.3 % in the right ventricule; in 36.7 % in
the left ventricule during the venous phase). In the circulat-
ing phase, the prevalence of contrast layering increased in
most vascular compartments except for some sites where the
contrast layer decreased and sometimes even disappeared.
These sites were the ascending aorta (minus 18.3 %), the
portal vein (minus 4.1 %) and the left cardiac ventricle
(minus 4 %). Contrast layering in the coronary arteries and
right atrium remained stable (unchanged) in all three angio-
graphic phases (6.1 % for the coronary arteries and 55.1 %
for the right atrium).
Degree of vessel opacification
Filling defects or inhomogeneous opacification without
layering (Fig. 8) was essentially observed in the cardiac cav-
ities. Prevalence reached 85 % for the left atrium, 53.1 % for
the left ventricle and 77.6 % for both the right cavities (atrium
and ventricle) in the arterial phase. Inhomogeneous
opacification was also observed in the pulmonary arteries in
83.7 % of cases during the arterial phase. However, the
Fig. 5 Evaluation of the
perfusion of neck and brain.
The different degrees of
perfusion are shown in different
colours for the venous and for
the dynamic phase according to
the colour scheme shown in
Fig. 1: from blue colour for no
opacification of the vessels (0)
to green for a complete
opacification of the cerebral
venous system (8). The
numbers in the figure
correspond to the number of
cases which have obtained the
corresponding degree
Fig. 4 Artefacts resulting from sample collection. a Diffuse contrast-
agent extravasations in the trajectory of the biopsy needles visible in both
lungs (yellow arrow). b Presence of gas in the trajectory of the needle and
contrast agent in pericardium (yellow arrow) resulting from the aspiration
of cardiac blood. c Contrast-agent extravasation and presence of gas
(yellow arrow) and around the gallbladder resulting from the passage of
the needle inserted for bile aspiration. d Presence of gas (yellow arrow) in
the trajectory of the needle resulting from collection of urine
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prevalence of this phenomenon decreased significantly with
the increasing number of performed angiographic phases. For
example in the pulmonary arteries, such artefacts remained
visible only in 4.1 % of the cases.
Artefacts caused by CT-guided fluid and tissue sampling
Artefacts related to the biopsy or needle tracts were not
frequently observed in the arterial phase (Fig. 9). In the venous
phase, however, their cumulative prevalence significantly in-
creased from 12.2 to 79.5 % for the right lung, from 8.2 to
59.2 % for the left lung, from 6.1 to 67.3 % for the gallbladder
and from 24.5 to 69.4 % for the right ventricle. The least
affected sampled site was the bladder, where artefacts were
never observed in the arterial phase. They were present in
10.2 % of cases in the venous phase, however.
Other artefacts
During the venous and circulating phases, contrast extrava-
sation from the right renal vein was observed in seven cases
(14.3 %).
Associations between artefacts and case information
Cause of death and BMI influenced the degree of opacification
of the neck and brain venous system (Table 4). Complete
perfusion was more frequently observed with lower BMI
(22.5 vs. 25.8; p=0.033) and in polytrauma cases (100 vs.
5.3 %; p<0.001). Likewise, a higher BMI was more frequently
associated with artefacts (Spearman’ rho=0.300; p=0.0366), as
opposed to polytrauma cases, in whom artefacts were less often
observed (3.2 vs. 5.2; p=0.004).
We did not find any correlation between the presence of
artefacts and age (Spearman’s rho=0.138; p=0.345) or time
since death (Spearman’s rho=0.174; p=0.232). However, we
noted that cases with reduced cerebral perfusion presented
also more artefacts in the second anatomical area including
thorax and abdomen (Spearman’s rho=−0.396; p=0.005).
Verification of the presence of artefacts
By comparing the described artefacts with the autopsy re-
ports, we could clearly identify those as artefacts and rule
out a misinterpretation of real findings (e.g. exclusion of
Fig. 6 Prevalence of gastrointestinal artefacts. a Diagram of the prev-
alence of an enhancement of the digestive mucosa, which was most
frequently observed in the gastric mucosa (81.6 %), followed by the
duodenal mucosa (65.3 %) and the colic mucosa (59.2 %) in the arterial
phase. The prevalence of this artefact increased slightly between the
other phases. b Diagram of the prevalence of mucous oedema, which
shows the same distribution in the arterial phase with smaller values
than that of a simple enhancement: 51 % for the gastric mucosa, 22.4 %
for the duodenal mucosa and 4.1 % for colon mucosa. A slight increase
of the prevalence can be observed after the venous and dynamic phase.
c Diagram of the prevalence of intraluminal contrast-agent extravasa-
tion and extravasation surrounding the pancreatic head. In the arterial
phase, this artefact could be observed in 20.4 % in the stomach and in
4.1 % in the duodenum but was never observed in the colic lumen.
Again, an increase in the prevalence could be observed after the
different phases, especially the venous phase. The prevalence of a
peripancreatic extravasation could be calculated as 46.9 % after the
arterial phase, with a slight increase during the venous phases (12.2 %)
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pulmonary embolism when an inhomogeneous opacification
of the pulmonary arteries has been described). In our study,
there was no case in which a pathological finding has been
interpreted as artefact.
Discussion
Our study evaluated and described the artefacts that can be
observed during interpretation of radiological images
obtained from postmortem CT angiography using MPMCTA.
AlthoughMPMCTA aims at mimicking in vivo physiology, the
perfusion conditions are reversed because the arterial system is
opacified in a retrograde fashion. Also postmortem changes can
influence the obtained radiological images. Such conditions
may favour the appearance of artefacts that differ from those
observed under normal physiologic conditions in life when the
beating heart distributes contrast peripherally.
In our department, forensic pathologists have been
performing joint interpretations with radiologists for the last
3 years. Based on our preliminary experience in more than
150 cases, we have noticed artefacts which have been ob-
served regularly. We could group three types of such
technique-related artefacts or pitfalls that may mimic path-
ologic findings: (1) incomplete venous opacification of the
head and neck vessels, (2) artefactual contrast enhancement
or extravasation of the gastrointestinal tract and (3) contrast
layering in the non-dependent aspect of vessels or
incomplete filling of the arterial or venous system. To sys-
tematically evaluate their prevalence, we performed this
study.
Concerning neck and brain perfusion, our systematic
evaluation of 49 consecutive MPMCTAs could show that
the arteries of the head and neck were always fully
opacified, independent of BMI or the postmortem delay. A
complete filling of the cerebral venous system, however,
was rarely observed. The reason the venous system is more
difficult to perfuse probably lies in the structural differences
between the wall composition of arteries and veins. Arteries
have a thicker muscular layer, allowing them to tolerate
higher pressures and to be more resistant to extravasation
than veins, which may explain why the arteries are so well
opacified. Conversely, veins have a thinner muscular layer
and are less resistant to higher pressures, despite their ca-
pacity to contain larger volumes. Of interest, the venous
system was more often fully perfused when trauma was
the cause of death. Because polytrauma victims typically
die in acute shock within seconds or minutes, it is possible
that vasoconstrictive factors may influence the antemortem
state of the venous system. In contrast to arteries, BMI
influenced the degree of venous filling, and adapting the
volume of contrast to BMI could lead to better venous
opacification, which is why we propose including this factor
in the standard MPMCTA protocol.
Concerning the digestive system, the artefacts can easily
be explained by enzymatic autolysis; we observed artefacts
Fig. 7 Prevalence of contrast
layering
Int J Legal Med (2013) 127:639–652 649
in organs with high enzymatic activity such as the gastric
mucosa and the pancreas. In our studies, these artefacts did
not depend on the postmortem delay, which was an unex-
pected finding. In the worst case, an extravasation of the
contrast agent into the gastric mucosa can be observed,
implying that when toxicological analysis of the gastric
content is important, the content should be extracted before
contrast agent injection to prevent contamination, or post-
mortem CT angiography should even be avoided. Because
an investigation for intoxication is not an indication for
MPMCTA, this characteristic does not appear to be a real
limitation. Another problem is the interpretation of
intragastric bleeding. This diagnosis should be made only
in cases in which a slight enhancement of the mucosa is
visible and not in cases where a clear oedema can be
observed. Therefore, radiologists and forensic pathologists
should handle the diagnosis of intragastric bleeding with
care, and the degree of gastrointestinal artefacts should be
considered when making such a diagnosis. In addition,
diagnosis of a peripancreatic bleeding can be performed
only in cases of clear signs of the bleeding on native CT
scans (i.e. presence of peripancreatic blood on the native CT
scan and extravasation of contrast agent in this exact region)
. The simple finding of contrast agent around the head of the
pancreas must be interpreted as artefact.
Concerning the vascular system, two types of artefacts
can be observed. One is the presence of a layer in the
arteries. Contrast layering was seen only in large vessels
such as the aortic arch, descending aorta and inferior vena
cava. The most important discriminating factor to use in
avoiding mistaking such artefacts for a dissection is the
interface between the overlying contrast layer and the de-
pendent blood. Angiofil® (a contrast agent consisting of
iodized linseed oil) typically forms a horizontal interface
with the underlying native blood. True dissection, on the
other hand, usually produces a semiluminar interface. The
second feature to consider is the aspect of the layer in the
different phases. A true dissection flap should be seen in all
phases, but an artefactual contrast layering will typically be
seen clearly in the arterial phase only, before fading or
disappearing in the venous and dynamic phases.
More difficult to interpret is the presence of filling defects
in the vascular system. As our study shows, such inhomo-
geneous opacification without layering appears mostly in
the cardiac cavities and the pulmonary arteries. If there is no
layer, these artefacts cannot be clearly identified as such
unless they change their appearance during the different
phases of angiography. However, as the correlation to the
autopsy finding showed, in most cases, these artefacts result
from huge postmortem clots that occlude the vascular lumen
and that can create images identical to those of real vascular
occlusion such as pulmonary embolism, even if these arte-
facts are without correlation to any vital coagulation pro-
cess. Unfortunately, the presence of the postmortem clots
Fig. 8 Prevalence of
inhomogeneous vessel
opacification (without contrast
layering)
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was not always described in the autopsy reports so that an
exact correlation of their prevalence and the appearance of
the artefact could not be analysed. We could not find a clear
difference between artefacts created by postmortem clots
and real embolism; thus, the diagnosis of an antemortem
pulmonary embolism should remain an autopsy diagnosis
and only be suspected but not confirmed after MPMCTA.
Nevertheless, in cases where we observed such filling arte-
facts, we identified them in many different parts of the
vascular system and not only in the pulmonary arteries.
These artefacts seem to be related to a prolonged phase of
agony (or deaths related to other causes than polytrauma).
For the practical use, this means that in cases with a long
period of agony with a high prevalence of such artefacts, it
is not possible to verify with certitude the presence of an
antemortem occlusion.
Perihilar renal contrast extravasation at the level of the
renal vein, particularly on the right side, was rarely observed
(seven cases). This location is the only one where this
phenomenon has ever been observed since MPMCTA was
introduced at our institution. One possible explanation is a
pressure-related rupture induced by our perfusion system.
The right renal vein might constitute the point of highest
pressure and vulnerability when contrast is injected through
the cannulated right femoral vein, which is the side most
often cannulated, although this remains to be seen. To
differentiate this artefactual contrast extravasation from a
perihilar hematoma (resulting from an antemortem lacerated
or injured renal vein, for example), the images should be
correlated with the initial native CT. If no spontaneous
density is present on the native study, extravasation should
be considered as an artefact.
Concerning the prevalence of artefacts and the parame-
ters of the examined bodies, we found that the most impor-
tant factor is the condition of death, especially the phase of
agony. Cases with no artefacts are mostly cases of
polytrauma and the frequency of artefacts, especially those
of the vascular system, increases with a prolonged phase of
agony. Therefore, this frequency of artefacts could indicate
whether death happened after a long phase of agony or not.
Of course, this hypothesis based on these data from our
work would require testing in further studies.
Finally, artefacts resulting from CT-guided tissue and
fluid sampling before contrast injection were frequently
observed. To differentiate pathologic extravasation from
sampling artefacts and avoid interpretation errors during
autopsy, we thus modified our MPMCTA protocol after
completion of the present study. To perform as few
sample collections as possible, the forensic pathologist
in charge of the case determines their necessity. As a
way to facilitate artefact recognition, biopsy needles and
needles for the liquid samples should remain in the
body after the sample collection during one short native
scan to indicate the position of each needle. In this way,
a potential artefact observed during autopsy can easily
be verified as such.
Fig. 9 Prevalence of fluid or
tissue sampling-related artefacts
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Limitations The present study tried to evaluated artefacts
which have been observed during the first years of
introduction of the MPMCTA into forensic pathology.
Our centre was the first one to use this new technique,
and therefore, until today no guidelines or recommen-
dations exists how to interpret the obtained images.
Starting with this major limitation, we tried to discover
pitfalls and to define artefacts that have been
recognised. Obviously, all described artefacts depend
therefore on the experience that we have made and
had been chosen in a subjective way. Although we tried
to establish a complete list of them and we had an
independent observer to view the data, we cannot guar-
antee that other users of the technique would have
found more artefacts that are not described here.
In summary, each technique performed on the body,
whether by conventional autopsy, histology or other exam-
inations, creates artefacts, but once the artefacts are well-
known and recognized as such, there is less danger of
misinterpretation. All artefacts that can be observed using
MPMCTA seem to be reproducible and stable in terms of
their localization and type, making them more or less easily
recognizable. The artefacts fall into three categories: related
to postmortem changes, related to the method and iatrogenic
artefacts related to the samples collections. An understand-
ing of these artefacts can help avoid misinterpretations dur-
ing radiological evaluation, and an understanding of their
meaning is important for guaranteeing a correct radiological
interpretation.
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